Organ Transport Devices Market

Organ Transport Devices Market Size, Market Forecast and Outlook By FMI

In 2025, the organ transport devices market was valued at USD 478.00 million. Based on Future Market Insights' analysis, demand is estimated to grow to USD 501.42 million in 2026 and USD 809.02 million by 2036. FMI projects a CAGR of 4.90% during the forecast period.

Summary of Organ Transport Devices Market

• Organ Transport Devices Market Definition
  • Organ transport devices are specialized containment and thermal management systems (insulated shipping containers, temperature-controlled perfusion transport units, GPS-tracked smart containers) used to maintain organ viability during ground and air transport from donor procurement site to recipient transplant centre, along with associated disposable kits, cold storage solutions, and slush preparation systems.
• Demand Drivers in the Market
  • TransMedics OCS adoption for heart and lung transport enables transplant programmes to accept donor organs from geographically distant procurement sites that exceed the 4 to 6 hour cold ischemia tolerance of static cold storage, expanding the effective donor matching radius by 50% to 100%.
  • Paragonix SherpaPak and SherpaPerfusion temperature-controlled shipping systems provide standardized thermal management for kidney and heart transport, replacing improvised ice cooler packaging with validated cold chain devices that maintain target temperature ranges throughout ground and air transit.
  • GPS-enabled organ transport tracking systems mandated by organ procurement organizations provide real-time location and temperature monitoring during transit, creating institutional demand for smart container systems that generate auditable chain-of-custody documentation.
• Key Segments Analyzed in the FMI Report
  • Devices product: 51.3% share in 2026, reflecting its structural position as the primary category across established procurement channels.
  • Kidney organ: 34.6% share in 2026, reflecting its structural position as the primary category across established procurement channels.
  • Hospitals end user: 66.8% share in 2026, reflecting its structural position as the primary category across established procurement channels.
  • Spain: 8.60% compound growth through 2036, indicating concentrated demand acceleration.
• Analyst Opinion at FMI
  • Sabyasachi Ghosh, Principal Consultant for Healthcare analysts observe that the organ transport devices market is a transplant logistics category where normothermic transport perfusion and standardized cold chain management are replacing improvised ice cooler-based organ shipping. FMI analysts observe that devices command 51.3% product share because transport containers and portable perfusion units generate the highest per-unit revenue, though disposable kits and solutions create recurring per-transport consumable revenue. Kidney at 34.6% organ share leads because kidney transplants represent the highest annual procedure volume globally and require transport more frequently than other organs due to the geographic distribution of dialysis-dependent recipient populations. Spain leads at 8.6% CAGR because the country's ONT organ procurement model, the most efficient globally per million population, generates the highest per-capita organ transport event frequency.
• Strategic Implications / Executive Takeaways
  • Transplant programmes should evaluate normothermic transport perfusion systems for heart and lung procurement from extended-distance donor sites to expand the donor matching pool beyond current geographic cold ischemia constraints.
  • Organ procurement organizations should standardize transport device procurement on validated temperature-controlled containers with GPS tracking to replace inconsistent improvised packaging that risks organ damage from temperature excursions during transit.
  • Transport device manufacturers should develop combined cold storage and perfusion transport platforms that enable procurement teams to initiate machine perfusion at the donor hospital and maintain continuous perfusion throughout ground and air transit without interruption.

The market is set to add approximately USD 307.60 million in absolute terms between 2026 and 2036. Transplant programme geographic expansion and normothermic transport perfusion adoption are sustaining market growth. TransMedics Organ Care System (OCS) for heart, lung, and liver transport has demonstrated that continuous normothermic perfusion during transit enables longer transport distances and expanded donor-recipient matching geography compared to static cold storage transport in conventional ice coolers.

As per FMI, country-level growth rates through 2036 are projected as follows: Spain at 8.60%, China at 7.90%, South Korea at 7.50%, India at 7.40%, France at 6.30%, Germany at 5.50%, Australia and New Zealand at 5.10%, USA at 4.70%. Spain records the fastest expansion driven by concentrated institutional investment.

Organ Transport Devices Market Key Takeaways

Metric	Details
Industry Size (2026)	USD 501.42 Million
Industry Value (2036)	USD 809.02 Million
CAGR (2026 to 2036)	4.90%

Source: Future Market Insights, 2026

Organ Transport Devices Market Definition

The organ transport devices market encompasses specialized containment, thermal management, and perfusion systems engineered for maintaining organ viability during transit from donor procurement site to transplant centre. Product categories span insulated static cold storage shipping containers, portable normothermic perfusion transport units, single-use disposable transport kits, cold storage and perfusion solutions, and slush preparation systems for creating organ preservation ice slurry. FMI is of the opinion that the market is transitioning from improvised ice cooler-based transport to standardized, validated, and increasingly perfusion-enabled transport devices, driven by clinical evidence demonstrating improved graft outcomes with controlled temperature management and continuous perfusion during transit.

Organ Transport Devices Market Inclusions

Market scope covers organ transport containers, portable perfusion transport units, disposable shipping kits, cold storage solutions, perfusion solutions, and slush preparation systems used in kidney, heart, lung, liver, pancreas, and intestine transport across hospital, transplant centre, and organ procurement organisation settings.

Organ Transport Devices Market Exclusions

Stationary organ preservation and perfusion equipment installed in transplant centre operating suites, general medical specimen transport containers, and blood product transport systems are excluded.

Organ Transport Devices Market Research Methodology

• Primary Research: Analysts conducted structured interviews with procurement managers, product engineers, and distribution channel operators to map purchase decision triggers and specification requirements across key verticals.
• Desk Research: Data collection aggregated regulatory filings, industry standards documentation, patent registries, trade body publications, and company annual reports across all target geographies.
• Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation of product shipment volumes and average selling prices, validated against publicly disclosed revenue figures from leading suppliers.
• Data Validation and Update Cycle: Projections are cross-referenced against quarterly earnings data, import-export trade statistics, and industry association production reports to maintain forecast integrity.

Key Organ Transport Devices Industry Trends

Rising Organ Transplantation Rates Is Increasing the Need for Organ Transport Devices and Fueling the Market Growth.

Rising end-stage organ failure and chronic diseases have resulted in rapid growth in the number of organ transplantations being performed around the world. The following are the significant factors responsible for this increased incidence: demographic shifts, changes in lifestyle, and improved diagnostic acumen.

Not only an ageing population, but also rising incidences of chronic diseases, including diabetes, cardiovascular diseases, and kidney diseases, bring a group of individuals whose organ failure needs a lifesaving transplantation intervention.

According to Global Observatory on Donation and Transplantation, Globally, the number of organ transplants has also been on the rise. In 2022, there were 157,494 organs transplanted worldwide, representing a 9.1% increase over 2021

Progressively, the medical techniques of transplants also evolved, in terms of transplants becoming readily available, fast, and productive. Minimally invasive procedures, better algorithms for immunosuppressive treatments, and appropriate organ matching contributed significantly to further improved transplant outcome and survival results, thus creating healthy quality of life among recipients.

Organ transport devices range from the development of temperature-controlled containers to more advanced perfusion solutions that attempt to closely match physiological conditions, all designed to optimize organ preservation under various conditions. These are crucial for preserving organs during transit.

Driving Innovations by Manufacturers for Improved Transplant Outcomes is favoring the Growth for Organ Transport Devices Market

Many companies are actively implementing various methods to create dynamic advances within the organ transport devices industry, given the constantly changing nature of the industry. With the ultimate objective of promoting sales growth and expansion, these organizations place a high priority on initiating new product launches, obtaining product approvals, and developing product development activities.

TransMedics Group, Inc. is one noteworthy example of this proactive strategy; the company just reached a major milestone with the USA FDA premarket approval for their OCS Liver System in September 2021.

The vital necessity for efficient organ preservation after donation after cardiac death (DCD) and donation after brain death (DCBD) is addressed by this ground-breaking method. The OCS Liver System uses state-of-the-art technology to make it easier to preserve and monitor donor livers' hemodynamic and metabolic processes, allowing for thorough ex-vivo evaluation.

Organ transport technology has advanced significantly with the approval of the OCS Liver System, especially for liver allografts. Assessing and optimizing donor liver appropriateness for transplantation is made possible by the OCS Liver System's capacity to preserve organ viability and function outside of the body. This discovery helps meet the increasing need for donor organs while also improving the effectiveness and success rates of liver transplant operations.

Increasing Growing Transplantation Centers, a Significant Market Driver for Organ Transport Devices Market

The number of kidney transplants is increasing and in the year 2022, as stated by the United Network for Organ Sharing, it saw an increase of 16% in the United States. Transplant centers are growing rapidly. Also, clinics that provide transplantation services are also witnessing a sharp rise in transplant procedures.

According to its annual report for 2021, Cleveland Clinic Abu Dhabi had its busiest year for organ transplants, with 117 performed in a single year. Within a year, the flagship Hospitals accomplished 56 kidneys, 46 liver, and 5 pancreas transplants, as well as 3 heart and seven combination transplants.

Development in medical technology, increased public knowledge of the merits of transplantation, and easier accessibility to health care services are a few of the reasons driving this growth. Demand for organ transport devices to carry and preserve organs for transplantation surgery is increasing alongside the growth in transplantation centers.

This pattern emphasizes how crucial it is to have a strong infrastructure and effective organ transport options in order to support excellent transplant outcomes and meet the world's expanding organ transplant need.

Limited Availability of Donor Organs and Logistical Challenges Is Emerging as Significant Growth Barrier for Organ Transport Devices Market.

Shortages of donor organs and logistics complications severely impair organ transport device development and their efficacy in the execution of successful transplants. There is a severe shortage of donor organs chronic as compared to increasing demand for transplantation, thereby leaving huge challenges to health care providers as they deal with the growing demands of the patient population for such life-saving interventions.

The lack of appropriate donor organs is one of the main problems, which is caused by a number of variables such as low organ donation rates, strict donor requirements, and differences in organ distribution. Patients on transplant lists frequently have to wait long periods of time due to this shortage, which exacerbates their medical problems and raises mortality rates.

For instance, Machine perfusion emerges as a critical solution to expand the donor pool, yet its adoption faces challenges. Despite the potential to increase organ viability and utilization, logistical barriers and resource constraints hinder widespread implementation.

Furthermore, the underutilization of donor organs is made worse by differences in access to transplant treatments, especially in underprivileged or rural locations. Maximizing organ usage and improving transplant outcomes is further hampered by limited availability to specialized organ transport technologies and infrastructure in these places.

Comparison of Sales Outlook from 2021 to 2025 vs Forecast to 2036

The future of organ transport devices is going to be marked by breakthroughs aimed at improving organ viability, extending transport times, and enhancing logistical efficiency. Advanced perfusion technologies, which continuously oxygenate and provide nutrients to organs during transit, are one such innovation. These systems simulate physiological conditions, thus preserving the organs better and leading to higher success rates in transplantation.

The other critical advancement is the integration of IoT and smart monitoring capabilities. These devices will enable real-time tracking of critical parameters such as temperature, pressure, and perfusion flow rates, ensuring that organs remain in optimal condition throughout the journey. Predictive analytics powered by AI could also play a role, offering insights to preemptively address any potential issues during transport.

The biocompatibility as well as miniaturized components will make the usability and portability better for these devices so they can be used across health care settings. Next, innovations in cryopreservation and normothermic machine perfusion of organs will probably increase the shelf life of the available organs and allow them to be transported over longer distances, thereby increasing the organ-sharing networks reach. As a whole, the sales will collectively progress with these advances that ensure successful transplantation and save human lives.

Market Concentration

Tier 1 companies comprise market leaders with a significant market share of 58.9% in global market. These companies engage in strategic partnerships and acquisitions to expand their product portfolios and access cutting-edge technologies. Additionally, they emphasize extensive clinical trials to validate the efficacy and safety of their products. Prominent companies in tier 1 include TrandMedis and XVIVO

Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 21.9% market share. They typically pursue partnerships with multispecialty hospitals and research organizations to leverage emerging technologies and expedite product development.

These companies often emphasize agility and adaptability, allowing them to quickly bring new products to market, additionally targeting specific types medical needs. Additionally, they focus on cost-effective production methods to offer competitive pricing. Prominent companies in tier 2 include Organ Recovery Systems (ORS), Bridge to Life Ltd., Paragonix Technologies, Inc, OrganOx and others.

Finally, Tier 3 companies, such as Global Transplant Solutions, X-Therma, Inc., RipplePak, BTP Surgical LLC and others. They specialize in specific products and cater to niche markets, adding diversity to the industry. Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the organ transport devices sales remains dynamic and competitive.

Country-wise Insights

The section below covers the industry analysis for the organ transport devices market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle Ease & Africa, is provided. The United States is anticipated to remain at the forefront in North America, with higher market share through 2036. In South Asia & Pacific, India is projected to witness a CAGR of 4.0% by 2036.

Countries	Value CAGR (2026 to 2036)
United States	4.7%
Germany	5.5%
China	7.9%
France	6.3%
India	7.4%
Spain	8.6%
Australia & New Zealand	5.1%
South Korea	7.5%

High Transplant Volume in United States Is Increasing the Adoption of Organ Transport Devices

United States organ transport devices market is poised to exhibit a CAGR of 4.7% between 2026 and 2036. Currently, it holds the highest share in the North American market.

Since the USA performs the highest rate of organ transplants in the world, this, in fact, is a major push factor rising with the market for organ transport devices. Transplants occur mainly because of the well-established organ donation system and the increasing incidence of end-stage organ failure. This intensified demand for transplants thus warrants a purposely made-in-hand setup for the safe and efficient delivery of organs across the country.

Organ transport devices have played an important part in ensuring organ viability during transportation from a donor to a recipient, especially given the continental distances across the USA Healthcare providers are constantly on the lookout for innovative means of transport to solve the logistic problems inflicting the demand.

With increased operations for transplants, advanced preservation techniques, including perfusion systems and real-time monitoring devices, will amplify investment for the adoption of cutting-edge solutions, thereby further projecting market growth.

High Number of Patient Pool for Organ Transplantation Is a Critical Driver for Market Growth in India

India organ transport devices market is poised to exhibit a CAGR of 7.4% between 2026 and 2036. Currently, it holds the highest share in the South Asia & Pacific market, and the trend is expected to continue during the forecast period.

The high patient cases requiring organ transplants significantly impact the growth rate of the market for organ transport devices. Because of the gigantic and increasing population that is afflicted increasingly with chronic disorders such as diabetes, hypertension, and liver, the demand for organs has seen immense growth. Hence, there exists a waiting list of growing size for the increase in number of patients to require kidney, liver, and other organ transplants.

The large patient pool requires effective and reliable transport systems to ensure that donated organs are preserved under optimal conditions during transit, especially in a vast country like India. The need for advanced transport devices is heightened because healthcare providers want to reduce the transplant rejection rate and improve the outcomes of the patients. This growing patient pool continues to drive the demand for innovative organ transport technologies in India.

The Country's Well-Established Regulatory and Healthcare Policies Support Organ Donation and Transplantation.

Germany’s organ transport devices market is poised to exhibit a CAGR of 5.5% between 2026 and 2036. Currently, it holds the highest share in the Western Europe market, and the trend is expected to continue during the forecast period.

A robust regulatory framework is in place for organ transport devices market growth in Germany. It is a country that has an already established set of healthcare policies and regulations for the donation, transplantation, and transportation of organs. Therefore, it guarantees efficiency and transparency in the process. Organizations like the German Organ Transplantation Foundation (DSO) manage the procurement and distribution of organs to create a smooth system for allocation and transport of organs.

This regulatory structure fosters trust and efficiency in organ donation and transplantation, which directly boosts the demand for advanced organ transport devices. With a clear and standardized process, healthcare providers are more likely to adopt cutting-edge transport technologies to maintain organ viability during transit. The regulatory support ensures that these devices are used effectively, providing a conducive environment for their widespread adoption and contributing to the growth of the organ transport devices market in Germany.

Category-wise Insights for Organ Transport Devices

The section contains information about the leading segments in the industry. By product, the devices segment holds the highest market share of 51.3% in 2026.

Devices Segment Continues to Hold the Highest Market Share in the Organ Transport Devices Outlook

By Product	Devices
Value Share (2026)	51.3%

The devices segment dominates the organ transport devices market due to the essential role these devices play in maintaining organ viability during transit. These devices, such as portable perfusion systems, cooling units, and advanced preservation machines, are critical for preventing organ damage by ensuring optimal conditions such as temperature control, oxygenation, and nutrient supply.

As the need for longer transportation times and organ sharing across regions increases, the reliance on these devices has grown. Their ability to preserve organs for extended periods has improved transplant success rates, driving their adoption. A robust regulatory framework is in place for organ transport devices market growth in Germany.

It is a country that has an already established set of healthcare policies and regulations for the donation, transplantation, and transportation of organs. Therefore, it guarantees efficiency and transparency in the process. Organizations like the German Organ Transplantation Foundation (DSO) manage the procurement and distribution of organs to create a smooth system for allocation and transport of organs.

Hospitals Dominate the Organ Transport Devices Market Due to Their Central Role in Healthcare Delivery

By End User	Hospitals
Value Share (2026)	66.8%

Hospitals have well-equipped specialized transplant units and skilled medical teams that manage the entire process of organ transplantation. The transplantation procedure requires very efficient systems to transport organs from one hospital to another while still preserving the viability of the organ.

Hospitals serve as procurement and recipient centers and coordinate organ donation and transplant patient admissions. Hospitals, therefore, stand at the top of organ transport requirements due to this central role. A hospital setting is required to ensure proper preservation, storage, and transportation, with trained staff and appropriate facilities for organ care. The need for sophisticated devices that guarantee the safe and effective transportation of organs in hospitals is enormous.

Top Players in the Organ Transport Devices Industry

The market players are using strategies to stay competitive, such as product differentiation through innovative formulations, strategic partnerships with healthcare providers for distribution. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.

Scope of the Report

Metric	Value
Quantitative Units	USD 501.42 Million to USD 809.02 Million, at a CAGR of 4.90%
Market Definition	Organ transport devices are specialized containment and thermal management systems (insulated shipping containers, temperature-controlled perfusion transport units, GPS-tracked smart containers) used to maintain organ viability during ground and air transport from donor procurement site to recipient transplant centre, along with associated disposable kits, cold storage solutions, and slush preparation systems.
Product Segmentation	Devices, Disposables, Cold Storage Solution, Perfusion Solution, Slush Preparation Solutions
Organ Segmentation	Kidney, Heart, Lung, Liver, Pancreas, Small Bowel/Intestine
End User Segmentation	Hospitals, Transplant Centers, Organ Procurement Organizations
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East & Africa
Countries Covered	Spain, China, South Korea, India, France, Germany, Australia and New Zealand, USA, and 40 plus countries
Key Companies Profiled	TransMedics, Bridge to Life Ltd., Paragonix Technologies, Inc, XVIVO, OrganOx, Organ Recovery Systems (ORS), X-Therma, Inc., Global Transplant Solutions, RipplePak, Vascular Perfusion Solutions, Inc
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down modeling validated against primary research inputs and publicly available industry data.

Key Segments Studied in the Organ Transport Devices Market Research Report

By Product:

In terms of product, the industry is divided into- devices, disposables, cold storage solution, perfusion solution and slush preparation solutions.

By Organ:

In terms of organ, the industry is segregated into- heart, lung, liver, kidney, pancreas, small bowel/intestine.

By End User:

In terms of end user, the industry is segregated into- hospitals, transplant centers, organ procurement organizations (OPOs).

By Region:

Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.

Bibliography

• [1] TransMedics Inc. (2024). Annual Report 2024: Organ Care System Product Line. TransMedics.
• [2] Paragonix Technologies. (2024). SherpaPak and SherpaPerfusion Transport Systems: Clinical Outcomes Data. Paragonix.
• [3] Organizacion Nacional de Trasplantes, Spain. (2024). ONT Annual Activity Report: Organ Procurement and Transport Statistics. ONT.
• [4] United Network for Organ Sharing. (2024). UNOS Policy: Organ Packaging, Labeling, and Transport Standards. UNOS.
• [5] World Health Organization. (2024). Global Observatory on Donation and Transplantation: Transport and Logistics Standards. WHO.

This bibliography is provided for reader reference. The full FMI report contains the complete reference list with primary research documentation.